Navigation Links
Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluge's Successor
Date:12/16/2013

PALO ALTO, Calif., Dec. 16, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that Robert H. Kluge has announced his intention to retire as its Senior Vice President and President, Imaging Components Businesses effective February 7, 2014.  Varian CEO Dow R. Wilson has named and the Board of Directors has appointed Sunny Sanyal, CEO of T-System, to succeed Kluge.  Varian's Imaging Components Businesses are comprised of the X-Ray Products and Security and Inspection Products businesses.

"Bob Kluge built Varian's X-Ray Products revenues from $75 million in 1993 to $546 million at the end of fiscal 2013," Wilson said.  "We are indebted to Bob for his strategic vision, intelligent management, and consistent execution that have propelled Varian to a leadership position in the global imaging industry.  He has set the stage for continued success and growth in our components businesses. 

"Sunny Sanyal is an experienced leader who will work with our seasoned imaging components management team to expand and capitalize on the growth potential for these businesses," Wilson said.  "We look forward under Sunny's leadership to building these businesses into a billion dollar platform for Varian." 

Sanyal, 49, will assume his position as Senior Vice President and President, Imaging Components Businesses on February 3, 2014.  Prior to joining T-System, a privately-held company providing information technology solutions and services to hospitals and urgent care facilities, Sanyal was president of McKesson Provider Technologies, where he led the company to significant market expansion with its clinical IT solutions.  He also worked for GE Healthcare, Accenture and IDX Systems. 

"I am excited to be a part of Varian," Sanyal said.  "Bob and team have built a tremendous business for Varian.  I look forward to working with the team to continue building these businesses through market expansion, continued innovation, and strong customer relationships."

Sanyal has an MBA from Harvard Business School, an MS in Industrial Engineering from Louisiana State University, and a bachelor's degree in Electrical Engineering from the University of Bombay.

Kluge, 67, will retire but support the leadership transition in an advisory capacity as needed.  "I have enjoyed building the X-ray Products business for Varian and I have been fortunate to have great relationships with our customers, Varian management, and the imaging components team," said Kluge. "I expect this team will continue to excel and that these businesses will thrive under Sunny's leadership."  

ABOUT VARIAN MEDICAL SYSTEMS
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,400 people who are located at manufacturing sites in North America, Europe, and China and 72 sales and support offices around the world. For more information, visit http://www.varian.com.

Forward-Looking Statements
Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry outlook, including growth drivers; the company's future orders, revenues, backlog, or earnings growth; future financial results; the ability of the company's technology and products to save lives; and any statements using the terms "will," "continue," "expect," "set the stage," "expand," "look forward," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include the company's ability to effectively integrate new management; the company's ability to retain the services of key personnel; the effect of global economic conditions; demand for the company's products; the company's ability to develop, commercialize, and deploy new products; the impact of competitive products and pricing; the potential loss of key distributors or partners; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

FOR INFORMATION CONTACT:
Spencer Sias (650) 424-5782
spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems Schedules First Quarter FY2014 News Release and Conference Call
2. Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
3. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
4. Varian Medical Systems Exhibits New Lightweight Wireless Flat-Panel Digital X-ray Image Detector for Imaging Extremities and for Neonatal Procedures
5. Regina E. Dugan Appointed to Board of Directors of Varian Medical Systems
6. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 6 Million Shares of Stock through Calendar Year 2014
7. Varian Medical Systems Exhibits New Flat-Panel Digital X-ray Image Detectors Designed for High Energy Industrial and Security Applications
8. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
9. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
10. EntreMed Commences Phase 2 Trial For ENMD-2076 In Ovarian Clear Cell Carcinomas
11. Merrimack Pharmaceuticals Announces Results From A Phase 2 Study Of MM-121 (SAR256212) In Combination With Paclitaxel In Patients With Platinum-Resistant Or Refractory Advanced Ovarian Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb.8, 2016 Cardiac Assist ... Summary GlobalData,s Medical Devices sector report, " ... 2015 " provides an overview of Cardiac Assist ... provides comprehensive information on the pipeline products with ... of development. The report reviews major players involved ...
(Date:2/8/2016)... Devices - Medical Devices Pipeline Assessment, 2015 Summary ... Medical Devices Pipeline Assessment, 2015" provides an overview of ... This report is prepared using data sourced from in-house ... industry experts. *Note: Certain sections in the report ... and relevance of data in relation to the equipment ...
(Date:2/8/2016)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... and year-end 2015 results after the Nasdaq market closes ... a live conference call and webcast to discuss its ... February 11, 2016 at 4:30 p.m. Eastern Time (1:30 ... http://www.neurocrine.com . --> Participants can access ...
Breaking Medicine Technology:
(Date:2/9/2016)... Altamonte Springs, FL (PRWEB) , ... February 09, ... ... nation’s leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It ... donations for each prescription referral received at our specialty pharmacy. , “Since ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul McElwee, ... after they noticed their furnace not producing any heat. Shortly after entering the home, ... heat exchanger was leaking dangerous levels of carbon monoxide into the home, at 2,000 ...
(Date:2/9/2016)... WI (PRWEB) , ... February 09, 2016 , ... ... Bergner’s, Boston Store, Carson’s, Elder-Beerman, Herberger’s and Younkers department stores, announced it has ... College of Wisconsin Cancer Center, Holden Comprehensive Cancer Center at the University of ...
(Date:2/9/2016)... Diego, California (PRWEB) , ... February 09, 2016 ... ... launch of their new nationwide service to expand access to affordable hearing ... 30 million hard of hearing individuals in the United States. , “For the ...
(Date:2/9/2016)... ... February 09, 2016 , ... IsoComforter, Inc., one of the ... newly designed, innovative shoulder wrap. The newly designed shoulder wrap has been ... arm and shoulder to promote faster healing. It is highly recommended for arm ...
Breaking Medicine News(10 mins):